Maynard Um
-
-
-
-
-
-
-
Marvel Biosciences Granted Chinese Patent for Lead Therapeutic Candidate MB-204
-
-
-
-
-
-
-
Marvel Biosciences Announces Notice of Allowance of Composition of Matter Patent for Its Lead Molecule MB-204 in China
-
-
-
-
-
-
-
Marvel Announces an Extension to Its Collaboration with The iBraiN Institute to Test MB204 In a Pre-Clinical Model of Rett Syndrome
-
401,065 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

